Clinical trials play a pivotal role in advancing our understanding and treatment of Alzheimer’s Disease and dementia. These trials focus on testing new medications, therapies, and interventions aimed at improving symptoms, slowing disease progression, or preventing onset. They involve diverse participant recruitment to ensure findings are applicable across different groups. Researchers rigorously evaluate safety, efficacy, and potential side effects of experimental treatments. Participation not only offers access to cutting-edge care but also contributes to scientific knowledge crucial for future advancements. By testing new approaches, these trials are instrumental in the ongoing pursuit of effective treatments and, ultimately, a cure for Alzheimer’s Disease and various types of dementia.
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jun Hua
Johns Hopkins University , United States
Jonathan Eskenazi
Cedars Sinai Medical Center, United StatesSubmit your abstract Today
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neurophysiological change and cognitive response to levetiracetam in Alzheimer disease: Testing the missing mechanistic link
Christopher Hubler, Emergent Neural Systems Institute for Research, United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda